We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+14.71%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$816B
AUM Growth
+$71.6B
Cap. Flow
-$12.2B
Cap. Flow %
-1.5%
Top 10 Hldgs %
32.14%
Holding
3,021
New
108
Increased
1,941
Reduced
738
Closed
64

Top Buys

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$2.03B
2
ROK icon
Rockwell Automation
ROK
+$1.44B
3
ADSK icon
Autodesk
ADSK
+$1.15B
4
C icon
Citigroup
C
+$975M
5
COP icon
ConocoPhillips
COP
+$967M

Sector Composition

Rank Sector Weight
1 Technology 32.21%
2 Healthcare 15.42%
3 Financials 10.99%
4 Consumer Discretionary 10.39%
5 Communication Services 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCO icon
2176
Clear Channel Outdoor Holdings
CCO
$1.18B
$534K ﹤0.01%
322,600
+17,901
+6% +$30.6K
CNXN icon
2177
PC Connection
CNXN
$2.04B
$534K ﹤0.01%
8,092
+499
+7% +$32.7K
UTI icon
2178
Universal Technical Institute
UTI
$1.42B
$532K ﹤0.01%
33,375
+3,446
+12% +$50K
ADAM
2179
Adamas Trust
ADAM
$907M
$531K ﹤0.01%
73,717
+3,723
+5% +$28.4K
MED icon
2180
Medifast
MED
$128M
$530K ﹤0.01%
13,828
+2,472
+22% +$120K
PUBM icon
2181
PubMatic
PUBM
$787M
$530K ﹤0.01%
22,311
+1,561
+8% +$28K
UMH
2182
UMH Properties
UMH
$1.42B
$530K ﹤0.01%
32,577
+2,158
+7% +$33K
BAM icon
2183
Brookfield Asset Management
BAM
$89.2B
$528K ﹤0.01%
12,573
+107
+0.9% +$4.33K
NABL icon
2184
N-able
NABL
$695M
$528K ﹤0.01%
40,372
+5,225
+15% +$69.1K
CENX icon
2185
Century Aluminum
CENX
$4.59B
$524K ﹤0.01%
34,013
+2,045
+6% +$23K
AMCX icon
2186
AMC Global Media
AMCX
$496M
$520K ﹤0.01%
42,811
+1,434
+3% +$21.8K
INBX
2187
DELISTED
Inhibrx, Inc. Common Stock
INBX
$518K ﹤0.01%
14,812
+1,112
+8% +$40.6K
CMP icon
2188
Compass Minerals
CMP
$1.1B
$516K ﹤0.01%
32,722
+1,358
+4% +$28.5K
DDD icon
2189
3D Systems Corp
DDD
$601M
$516K ﹤0.01%
116,215
+16,621
+17% +$81.8K
ONT
2190
Onterris Inc
ONT
$615M
$514K ﹤0.01%
13,104
+1,211
+10% +$40.6K
MODN
2191
DELISTED
MODEL N, INC.
MODN
$513K ﹤0.01%
18,018
+1,193
+7% +$31.5K
SLCA
2192
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$512K ﹤0.01%
41,192
+3,276
+9% +$36.7K
BATRK icon
2193
Atlanta Braves Holdings Series B
BATRK
$3.41B
$508K ﹤0.01%
12,995
+1,650
+15% +$64.9K
LTC
2194
LTC Properties
LTC
$2.1B
$508K ﹤0.01%
15,596
-6,392
-29% -$204K
CXM icon
2195
Sprinklr
CXM
$1.65B
$506K ﹤0.01%
41,179
-148,351
-78% -$1.89M
LBRDA icon
2196
Liberty Broadband Class A
LBRDA
$5.29B
$505K ﹤0.01%
8,838
+540
+7% +$35.6K
SABR icon
2197
Sabre
SABR
$892M
$505K ﹤0.01%
208,510
+13,554
+7% +$45.5K
CPF icon
2198
Central Pacific Financial
CPF
$1B
$504K ﹤0.01%
25,507
+1,020
+4% +$19.5K
NRC icon
2199
NRC Health Common Stock
NRC
$471M
$503K ﹤0.01%
12,686
+4,637
+58% +$183K
UNFI icon
2200
United Natural Foods
UNFI
$2.94B
$500K ﹤0.01%
43,493
+1,994
+5% +$29K

Similar funds

T. Rowe Price Associates's Q1 2024 Portfolio in Review

As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
  • T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
  • T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
  • T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
  • T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.